Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 15Fallopian Tube Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 5Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Brain Neoplasms 2Appendiceal Neoplasms 2Adrenocortical Carcinoma 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Peritoneal Cavity Cancer 1Peritoneal Cancer 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroblastoma 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Cytoreduction Surgical Procedures × Clear all
NCT01257594 2023-05-25

EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas

Columbia University

Phase 1 Completed
22 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT02238496 2023-05-25

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Columbia University

Phase 1 Completed
10 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡